| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.253 | 0 | 2.105 | 0 | 0 | 21.663 | 22.076 | 29.820 | 36.468 | 38.512 |
| Total Income - EUR | 12.284 | 1.856 | 2.105 | 0 | 0 | 21.663 | 22.076 | 29.820 | 36.468 | 38.655 |
| Total Expenses - EUR | 7.734 | 3.317 | 4.856 | 0 | 38 | 8.943 | 12.993 | 18.089 | 33.088 | 44.167 |
| Gross Profit/Loss - EUR | 4.550 | -1.461 | -2.751 | 0 | -38 | 12.721 | 9.083 | 11.731 | 3.380 | -5.511 |
| Net Profit/Loss - EUR | 4.182 | -1.517 | -2.814 | 0 | -38 | 12.117 | 8.434 | 11.146 | 3.060 | -5.898 |
| Employees | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Sil Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.996 | 16.708 | 15.054 | 14.778 | 14.492 | 15.486 | 12.523 | 10.457 | 39.797 | 30.422 |
| Current Assets | 63.499 | 61.726 | 60.516 | 59.377 | 59.300 | 16.042 | 14.795 | 15.086 | 1.052 | 1.641 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.364 | 0 | 2.544 | 2.497 | 0 | 2.612 | 6.224 | 10.537 | 0 | 1.321 |
| Cash | 61.135 | 61.726 | 57.972 | 56.880 | 59.300 | 13.431 | 8.571 | 4.549 | 1.052 | 320 |
| Shareholders Funds | 80.271 | 77.935 | 73.803 | 72.448 | 73.108 | 30.346 | 26.259 | 11.195 | 3.716 | -2.203 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.225 | 498 | 1.767 | 1.706 | 683 | 1.183 | 1.060 | 14.348 | 37.133 | 33.696 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 588 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Sil Med S.r.l.